Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.495 USD | -1.11% | -3.41% | -13.89% |
Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.89% | 2.04B | |
+2.94% | 108B | |
+9.09% | 105B | |
+0.55% | 23.46B | |
-14.48% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.73% | 17.19B | |
+5.59% | 13.99B | |
+36.67% | 12.53B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing